Fig. 5. LOXL1 prevents BAG2 ubiquitylation at K186.
a Overexpression of LOXL1 in U87 cells reduced BAG2 ubiquitylation. An antibody against BAG2 was applied to enrich the BAG2 protein levels, and BAG2 ubiquitylation was then tested. b Depletion of LOXL1 in LN18 cells enhances BAG2 ubiquitylation. c Mutation of K186 to R186 decreased BAG2 ubiquitylation. U87 cells were transiently transfected with the corresponding plasmids. BAG2 was tagged with FLAG and then immunoprecipitated with an antibody against FLAG. d K186 in BAG2 was mutated to R186 in LN18 cells, and BAG2 ubiquitylation was then tested. e MS analysis identified BAG2 K186 ubiquitylation. The spectrum of the ubiquitylation-modified K186 peptide was identified with an m/z value of 623.33 and a SEQUEST XCorr value of 2.62. f, g Both LOXL1 enzymatic activity and D515 were required for preventing the ubiquitylation of BAG2 at K186 and stabilizing the BAG2 protein. h, i Prevention of BAG2 K186 ubiquitylation enhanced the antiapoptotic activity of glioma cells.